A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
A Multicenter, Phase III, Open-Label, Randomized Study in Previously Untreated Patients With Advanced Indolent Non-Hodgkin's Lymphoma Evaluating the Benefit of GA101 (RO5072759) Plus Chemotherapy Compared With Rituximab Plus Chemotherapy Followed by GA101 or Rituximab Maintenance Therapy in Responders
Sponsor: German Low Grade Lymphoma Study Group
Listed as NCT01332968, this PHASE3 trial focuses on Non-Hodgkin's Lymphoma and remains completed. Sponsored by German Low Grade Lymphoma Study Group, it has been updated 25 times since 2011, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
25 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Sep 2022 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2022 — Sep 2022 [monthly]
Completed PHASE3
▶ Show 20 earlier versions
-
Feb 2022 — Jun 2022 [monthly]
Completed PHASE3
-
Jan 2022 — Feb 2022 [monthly]
Completed PHASE3
-
Nov 2021 — Jan 2022 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Sep 2021 — Nov 2021 [monthly]
Active Not Recruiting PHASE3
-
May 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE3
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting PHASE3
-
Jul 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE3
-
May 2020 — Jul 2020 [monthly]
Active Not Recruiting PHASE3
-
Feb 2020 — May 2020 [monthly]
Active Not Recruiting PHASE3
-
Nov 2019 — Feb 2020 [monthly]
Active Not Recruiting PHASE3
-
Aug 2019 — Nov 2019 [monthly]
Active Not Recruiting PHASE3
-
May 2019 — Aug 2019 [monthly]
Active Not Recruiting PHASE3
-
Jan 2019 — May 2019 [monthly]
Active Not Recruiting PHASE3
-
Oct 2018 — Jan 2019 [monthly]
Active Not Recruiting PHASE3
-
Aug 2018 — Oct 2018 [monthly]
Active Not Recruiting PHASE3
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting PHASE3
-
Jan 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
-
Jul 2017 — Jan 2018 [monthly]
Active Not Recruiting PHASE3
-
Feb 2017 — Jul 2017 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Jul 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- German Low Grade Lymphoma Study Group
- Hoffmann-La Roche
- Institute of Cancer Research, United Kingdom
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aberdeen, United Kingdom , Aichi, Japan , Alcorcón, Spain , Angers, France , Aomori, Japan , Badalona, Spain , Beijing, China , Bergamo, Italy , Berlin, Germany , Bilbao, Spain and 143 more locations